Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 2/20 | 0.46 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.46 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.46 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.46 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.44 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.44 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.43 |
| ▸ | DHFR | P00374 | 1/20 | 0.42 |
| ▸ | GPR34 | Q9UPC5 | 3/20 | 0.42 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8567609 | 0.84 | LTB4R (0.61) | LTB4RLTB4R2 | |
| SCHEMBL8562654 | 0.84 | PTGER1 (0.45) | PTGER1PTGER4PTGER3PTGER2LTB4R | |
| SCHEMBL8568217 | 0.82 | LTB4R (0.64) | LTB4RLTB4R2 | |
| SCHEMBL6899274 | 0.79 | NR1H4 (0.48) | — | |
| SCHEMBL8564848 | 0.78 | MAOB (0.51) | PTGER1PTGER4PTGER3PTGER2LTB4R | |
| SCHEMBL6897555 | 0.78 | NR1H4 (0.50) | — | |
| SCHEMBL6035792 | 0.78 | CYP4F2 (0.50) | PTGER1PTGER4PTGER3PTGER2CYP4F2 | |
| SCHEMBL6807773 | 0.77 | NR1H4 (0.47) | — | |
| SCHEMBL7901019 | 0.77 | FFAR1 (0.51) | PTGER1PTGER4PTGER3PTGER2CYP4F2 | |
| SCHEMBL23218790 | 0.76 | CYP4F2 (0.44) | CYP4F2CYP4A11GPR34 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0544488-B1 | Substituted phenyl phenol leukotriene antagonists | LILLY CO ELI (US) | 1998-03-11 | — | — | EP | disclosed |
| WO-1996036347-A1 | USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE | ELI LILLY AND COMPANY (US) | 1996-11-21 | — | — | WO | disclosed |
| EP-0743064-A1 | Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease | ELI LILLY AND COMPANY (US) | 1996-11-20 | — | — | EP | disclosed |
| US-5462954-A | Antiinflammatory, antiallergens; treating asthma | ELI LILLY AND COMPANY (US) | 1995-10-31 | — | — | US | disclosed |
| EP-0544488-A2 | Substituted phenyl phenol leukotriene antagonists | ELI LILLY AND COMPANY (US) | 1993-06-02 | — | — | EP | disclosed |